Project Grant R21AI185145
Award Date
5/1/25
Completion Date
4/30/27
Dollars Obligated
$193K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
This federal Project Grant award, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research focused on understanding the role of proinflammatory and regulatory B cells in alloimmune responses. The $2,647,283 grant, awarded on June 17, 2024, will enable the University of Pittsburgh to further define the transcriptome and signaling pathways regulating inflammatory B cell (Beff) function,...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $246,623 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to New York University School of Medicine to conduct research on the molecular control of tolerogenic dendritic cell function. The research aims to pinpoint the specific dendritic cell subset responsible for regulating immune tolerance, characterize the molecular basis including aberrant cytokine production and signaling impairment, and...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $2,245,701 to the University of Pittsburgh to research mechanisms of allergen-induced tolerance in the lung. The goal is to develop a better understanding of how repeated exposure to low doses of allergens, such as house dust mite, can prevent adverse reactions upon subsequent exposure. Key focus areas include...
This $567,962 project grant from the National Institutes of Health National Institute of Allergy and Infectious Diseases will fund research at the University of Alabama at Birmingham from March 2022 to February 2027 under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant will support research into the coordination of innate and adaptive immunity in intestinal barrier defense. Specifically, the grantee will define the mechanisms by which innate and adaptive immune...
This federal Project Grant award of $466,500.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to explore the role of the gut microbiota-stromal cell axis in influencing B-cell responses and antibody production following vaccination. The key objectives are to 1) identify gut stromal cell populations that fail to produce immune factors for B-cell development and antibody production, and 2)...
This Project Grant award in the amount of $884,454 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research aimed at investigating the immunomodulatory effects of secondary bile acids produced by the gut bacterium [Ruminococcus] gnavus. The research team is engineering a two-strain bacterial consortium to toggle the production of the secondary bile acid isodeoxycholic...
This Project Grant award, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research at the University of California, San Diego (UCSD) to investigate mechanisms of microbial competition in the gut during Salmonella infection. The $126,096 award, effective from January 17, 2025 to July 16, 2025, will employ metatranscriptomics and a novel sequencing approach called...
This federal Project Grant award of $827,922.00 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award will fund a research project at the University of California, San Diego that aims to elucidate new mechanisms of competition between the pathogen Salmonella enterica serovar Typhimurium (STM) and the gut microbiota. The project will utilize cutting-edge multi-omics approaches,...
The University of Pittsburgh - Of The Commonwealth System of Higher Education received a $612,975 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant is for a project titled "Targeting Monocyte Allorecognition to Achieve Allograft Acceptance" with the goal of developing long-term acceptance of organ transplants without the need for chronic immunosuppression. The...
This $864,735 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to identify the genetic and immunological mechanisms by which some mouse strains are able to generate neutralizing antibodies against retroviral infections through a previously uncharacterized, Toll-like receptor 7 (TLR7)-independent pathway. The research will elucidate the alternative innate immune...